NAD+

NAD+ is an essential cellular redox cofactor and substrate for enzymes including sirtuins, PARPs, and cyclic ADP-ribose synthases. Research spans energy metabolism, DNA repair, stress signaling, and aging biology.

Cycles between oxidized NAD+ and reduced NADH in redox reactions and is consumed by multiple signaling enzymes.

Extensive biochemical evidence; clinical evidence for direct NAD+ administration is limited and route-specific.

Level III, Limited route-specific human evidence

Evidence on NAD+ precursors cannot be automatically applied to direct NAD+ administration. Stability, oxidation state, purity, and delivery strongly affect interpretation.

Direct-administration safety is incompletely characterized and may include infusion reactions, chest discomfort, nausea, vascular effects, or contamination-related risks.

Endogenous metabolite; specific injectable or research preparations are not automatically FDA-approved.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

• NAD+, 500 mgLyophilized
• NAD+, 1,000 mgLyophilized

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.